Slide
EORTC Anniversary - Identity

EORTC ANNIVERSARY

Celebrating the Past, Inspiring the Future

Programme

Friday 30 September 2022

Session 1

EORTC: reflect on the past to build the future

10:15 – 11:05 Part 1: EORTC, all was about a vision
Chairs: W. van der Graaf (The Netherlands) & D. Lacombe (Belgium)
10:15 – 10:25 Video: EORTC, past, present and future
10:25 – 10:35 Welcome by EORTC President
Speaker: W. van der Graaf (The Netherlands)
10:35 – 10:45 Welcome by Honorary President of ECRF-EORTC
Speaker: HRH Princess Dina Mired (Jordan)
10:45 – 11:05 Keynote Lecture: 60 years of EORTC
Speaker: J. Verweij (The Netherlands)
11:05 – 12:15 Part 2: Past Presidents Forum
Chairs: J. Verweij (The Netherlands) and L. Licitra (Italy)

Questions related to their presidency, changes that have happened and looking to the future.
Panel: J.-C. Horiot (Switzerland) President 1997-2000
A. M. Eggermont (The Netherlands) President 2003-2006
M. Piccart (Belgium) President 2006-2009
J.-Y. Blay (France) President 2009-2012
R. Stupp (USA) President 2012-2017
B. Tombal (Belgium) President 2017-2021
12:15 – 13:15 Lunch

Session 2

13:15 – 15:00 Multidisciplinary clinical cancer research in the 21st Century
Chairs: E. Eisenhauer (Canada) and M. Piccart (Belgium)
13:15 – 13:35 Targeting the immune system: lessons from the Melanoma Group
Speaker: A. M. Eggermont (The Netherlands)
13:35 – 13:50 EORTC network agility alongside the evolution of science: lesson learned from the Lung Group.
Speaker: B. Besse (France)
13:50 – 14:35 Multidisciplinary clinical cancer research: where do we go from here?
Chairs: E. Eisenhauer (Canada) & M. Piccart (Belgium)
Panel: I. Lugowska (Poland)
P. Ost (Belgium)
F. van Duijnhoven (The Netherlands)
E. Giovannetti (The Netherlands)
14:35 – 15:00 The importance of clinical research for cancer patients
Speaker: J. Geissler (Germany)
15:00 – 15:20 Coffee break

Session 3

15:20 – 16:15 An alliance for independent clinical cancer research: creating opportunities
Chairs: R. Stupp (USA) & V. Golfinopoulos (Belgium)
Panel: D. Cameron (UK), Breast International Group
J-Y. Blay (France), UNICANCER and Centre Léon Bérard
M. Vignetti (Italy), Fondazione GIMEMA Franco Mandelli Onlus
L. Paz-Ares (Spain), Hospital Universitario 12 de Octubre
U. Keilholz (Germany), Charité – Universitätsmedizin Berlin
J. H. Doroshow (USA), National Cancer Institute
J. Dancey (Canada), Canadian Cancer Trials Group
16:15 – 16:20 Concluding remarks, insight into the future of academic partnerships
Speaker: R. Stupp (USA)
16:20 – 16:30 Cancer Clinical Research in the Middle East: Emerging Opportunities?
Speaker: A. H. Mansour (Jordan)

Session 4

16:30 – 17:30 Clinical cancer research: a European vision
Chairs: J.-Y. Blay (France) & D. Lacombe (Belgium)
Panel: M. Aapro (Switzerland), European Cancer Organisation
C. Chomienne (France), Horizon Europe Cancer Mission Board, European Commission
L. Meheus (Belgium), Anticancer Fund
Y. Natsis (Belgium), European Social Insurance Platform
J. F. Ryan (Luxembourg), DG for Health and Food Safety, European Commission
F. Pignatti (The Netherlands), European Medicines Agency

Session 5

17:30 – 17:45 Closing Remarks
Speaker: W. van der Graaf (The Netherlands)